[Insert Table 3 here]
Of all potentially preventable drug-related revisits (n=85), 56 (44 readmissions and 12 ED visits) were preceded by a hospital-based medication review in the MedBridge trial (Figure 2). Of these visits, 22 (39%) could potentially have been prevented by that intervention. None of the visits seemed to have been caused by the medication review.
Five patient cases are described in Table 4 to exemplify the diseases related to and causes of preventable drug-related revisits, their origin in healthcare and whether the revisits could have been prevented by the medication review performed during the MedBridge trial.